$Phio Pharmaceuticals (PHIO.US)$ NEWS Phio Pharmaceuticals A...
NEWS
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
MARLBOROUGH, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced it is presenting new data about its lead clinical product candidate, PH-762, an INTASYL compound. Preclinical studies demonstrate that PH-762 is effective in silencing PD-1, boosting immune response, and inhibiting tumor growth. PH-762 is currently being studied in a U.S. clinical trial to assess safety and efficacy in specific skin cancers (NCT 06014086). The data will be presented at the American Society of Cell and Gene Therapy (ASCGT) on May 8th in Baltimore, Maryland. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
Presentation Date: May 8 12PM EST
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
453Followers
65Following
2879Visitors
Follow
Trytosaveabit : GM! Feeling any better?
Jaguar8OP Trytosaveabit: Dizzy right now.
Might skip trading today or maybe past 11AM I feel nauseous. I suspect my glucose is low
Trytosaveabit Jaguar8OP: Sry! Maybe check your sugar?
Jaguar8OP Trytosaveabit: I will. Thanks brother
Trytosaveabit Jaguar8OP: Feel better
dSuu Jaguar8OP: hope you feel better
Qui Vivra Verra Jaguar8OP: Take care